Maia Biotechnology Administers Medication to the First American Patient in an Ongoing Phase II Clinical Trial for Non-Small Cell Lung Cancer
2026-09-16 20:16:56
According to CoinMeta, as reported by Reuters, Maia Biotechnology administered the treatment to the first American patient in the ongoing Phase II clinical trial for non-small cell lung cancer.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.